Ron Brookmeyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ron Brookmeyer has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Christina Michelle Ramirez Kitchen
Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA
5 shared publications - Jarvis T. Chen
Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health , Boston, MA
5 shared publications - Jay J. Xu
Department of Biostatistics, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA 90095, USA
5 shared publications - Marc A. Suchard
Department of Biostatistics, Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA
5 shared publications - Thomas R. Belin
Department of Biostatistics, University of California, Los Angeles, CA
5 shared publications - Claudia H. Kawas
Department of Neurobiology and Behavior, University of California, Irvine
3 shared publications
Latest Publications
- 1 July 2026
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 40 (3) , 175-182
Hypertension and 10-Year Dementia Risk Among Older Asian American and Non-Latino White Adults in Northern California
Introduction: Hypertension is a modifiable risk factor for dementia, but its contribution among Asian American ethnic groups remains understudied despite heterogeneity in cardiovascular risk factors. Methods: Participants were Kaiser Permanente Northern California members aged 60 to 90 years without prevalent dementia at baseline, surveyed between 2002 and 2009 [Chinese (n=4,848), Filipino (n=4,130), Japanese (n=2,786), South Asian (n=823), non-Latino White (n=123,593)]. We used ICD-codes to identify hypertension (assessed 5 y before baseline) and incident dementia through 2020. Within strata of race/ethnicity and baseline age group (60 to 75 and 75 to 90 y), we estimated adjusted and standardized 10-year dementia risk, risk ratios, risk differences, and population attributable fractions (PAFs) using pooled logistic regression, treating death as a censoring event. Results: Among Chinese, Filipino, Japanese, and non-Latino White participants aged 60 to 75 years, PAFs (95% CI) were 12% (−3% to 28%), 23% (4% to 40%), 9% (−7% to 27%), and 8% (5% to 10%), respectively. Effect estimates were null for these groups among participants aged 75 to 90. For South Asian participants, point estimates were consistent with protective associations among those aged 60 to 75 and harmful associations among those aged 75 to 90, although estimates were imprecise. Conclusion: Our findings suggest heterogeneity in the effect of hypertension on dementia risk across Asian American ethnic groups and by age.
- 1 July 2026
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 40 (3) , 175-182
Hypertension and 10-Year Dementia Risk Among Older Asian American and Non-Latino White Adults in Northern California
Introduction: Hypertension is a modifiable risk factor for dementia, but its contribution among Asian American ethnic groups remains understudied despite heterogeneity in cardiovascular risk factors. Methods: Participants were Kaiser Permanente Northern California members aged 60 to 90 years without prevalent dementia at baseline, surveyed between 2002 and 2009 [Chinese (n=4,848), Filipino (n=4,130), Japanese (n=2,786), South Asian (n=823), non-Latino White (n=123,593)]. We used ICD-codes to identify hypertension (assessed 5 y before baseline) and incident dementia through 2020. Within strata of race/ethnicity and baseline age group (60 to 75 and 75 to 90 y), we estimated adjusted and standardized 10-year dementia risk, risk ratios, risk differences, and population attributable fractions (PAFs) using pooled logistic regression, treating death as a censoring event. Results: Among Chinese, Filipino, Japanese, and non-Latino White participants aged 60 to 75 years, PAFs (95% CI) were 12% (−3% to 28%), 23% (4% to 40%), 9% (−7% to 27%), and 8% (5% to 10%), respectively. Effect estimates were null for these groups among participants aged 75 to 90. For South Asian participants, point estimates were consistent with protective associations among those aged 60 to 75 and harmful associations among those aged 75 to 90, although estimates were imprecise. Conclusion: Our findings suggest heterogeneity in the effect of hypertension on dementia risk across Asian American ethnic groups and by age.
- 5 July 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (5) , 1304-1313
Estimating dementia incidence in insured older Asian Americans and Pacific Islanders in California: an application of inverse odds of selection weights
Literature shows heterogeneous age-standardized dementia incidence rates across US Asian American, Native Hawaiian, and Pacific Islanders (AANHPI), but no estimates of population-representative dementia incidence exist due to lack of AANHPI longitudinal probability samples. We compared harmonized characteristics between AANHPI Kaiser Permanente Northern California members (KPNC cohort) and the target population of AANHPI 60+ with private or Medicare insurance using the California Health Interview Survey. We used stabilized inverse odds of selection weights (sIOSW) to estimate ethnicity-specific crude and age-standardized dementia incidence rates and cumulative risk by age 90 in the target population. Differences between the KPNC cohort and target population varied by ethnicity. The sIOSW eliminated most differences in larger ethnic groups; some differences remained in smaller groups. Estimated crude dementia incidence rates using sIOSW (vs unweighted) were similar in Chinese, Filipinos, Pacific Islanders and Vietnamese, and higher in Japanese, Koreans, and South Asians. Unweighted and weighted age-standardized incidence rates differed for South Asians. Unweighted and weighted cumulative risk were similar for all groups. We estimated the first population-representative dementia incidence rates and cumulative risk in AANHPI ethnic groups. We encountered some estimation problems, and weighted estimates were imprecise, highlighting challenges using weighting to extend inferences to target populations.
- 5 July 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (5) , 1304-1313
Estimating dementia incidence in insured older Asian Americans and Pacific Islanders in California: an application of inverse odds of selection weights
Literature shows heterogeneous age-standardized dementia incidence rates across US Asian American, Native Hawaiian, and Pacific Islanders (AANHPI), but no estimates of population-representative dementia incidence exist due to lack of AANHPI longitudinal probability samples. We compared harmonized characteristics between AANHPI Kaiser Permanente Northern California members (KPNC cohort) and the target population of AANHPI 60+ with private or Medicare insurance using the California Health Interview Survey. We used stabilized inverse odds of selection weights (sIOSW) to estimate ethnicity-specific crude and age-standardized dementia incidence rates and cumulative risk by age 90 in the target population. Differences between the KPNC cohort and target population varied by ethnicity. The sIOSW eliminated most differences in larger ethnic groups; some differences remained in smaller groups. Estimated crude dementia incidence rates using sIOSW (vs unweighted) were similar in Chinese, Filipinos, Pacific Islanders and Vietnamese, and higher in Japanese, Koreans, and South Asians. Unweighted and weighted age-standardized incidence rates differed for South Asians. Unweighted and weighted cumulative risk were similar for all groups. We estimated the first population-representative dementia incidence rates and cumulative risk in AANHPI ethnic groups. We encountered some estimation problems, and weighted estimates were imprecise, highlighting challenges using weighting to extend inferences to target populations.
- 17 April 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 193 (9) , 1261-1270
Heterogeneity in the effect of type 2 diabetes on dementia incidence in a diverse cohort of Asian American and non-Latino White older adults
Dementia incidence is lower among Asian Americans than among Whites, despite higher prevalence of type 2 diabetes, a well-known dementia risk factor. Determinants of dementia, including type 2 diabetes, have rarely been studied in Asian Americans. We followed 4846 Chinese, 4129 Filipino, 2784 Japanese, 820 South Asian, and 123 360 non-Latino White members of a California-based integrated health-care delivery system from 2002 to 2020. We estimated dementia incidence rates by race/ethnicity and type 2 diabetes status, and we fitted Cox proportional hazards and Aalen additive hazards models for the effect of type 2 diabetes (assessed 5 years before baseline) on age of dementia diagnosis, controlling for sex/gender, educational attainment, nativity, height, race/ethnicity, and a race/ethnicity × diabetes interaction. Type 2 diabetes was associated with higher dementia incidence in Whites (hazard ratio [HR] = 1.46; 95% CI, 1.40-1.52). Compared with Whites, the estimated effect of diabetes was larger in South Asians (HR = 2.26; 95% CI, 1.48-3.44), slightly smaller in Chinese (HR = 1.32; 95% CI, 1.08-1.62) and Filipino (HR = 1.31; 95% CI, 1.08-1.60) individuals, and similar in Japanese individuals (HR = 1.44; 95% CI, 1.15-1.81). Heterogeneity in this association across Asian subgroups may be related to type 2 diabetes severity. Understanding this heterogeneity may inform prevention strategies to prevent dementia for all racial and ethnic groups.
- 17 April 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 193 (9) , 1261-1270
Heterogeneity in the effect of type 2 diabetes on dementia incidence in a diverse cohort of Asian American and non-Latino White older adults
Dementia incidence is lower among Asian Americans than among Whites, despite higher prevalence of type 2 diabetes, a well-known dementia risk factor. Determinants of dementia, including type 2 diabetes, have rarely been studied in Asian Americans. We followed 4846 Chinese, 4129 Filipino, 2784 Japanese, 820 South Asian, and 123 360 non-Latino White members of a California-based integrated health-care delivery system from 2002 to 2020. We estimated dementia incidence rates by race/ethnicity and type 2 diabetes status, and we fitted Cox proportional hazards and Aalen additive hazards models for the effect of type 2 diabetes (assessed 5 years before baseline) on age of dementia diagnosis, controlling for sex/gender, educational attainment, nativity, height, race/ethnicity, and a race/ethnicity × diabetes interaction. Type 2 diabetes was associated with higher dementia incidence in Whites (hazard ratio [HR] = 1.46; 95% CI, 1.40-1.52). Compared with Whites, the estimated effect of diabetes was larger in South Asians (HR = 2.26; 95% CI, 1.48-3.44), slightly smaller in Chinese (HR = 1.32; 95% CI, 1.08-1.62) and Filipino (HR = 1.31; 95% CI, 1.08-1.60) individuals, and similar in Japanese individuals (HR = 1.44; 95% CI, 1.15-1.81). Heterogeneity in this association across Asian subgroups may be related to type 2 diabetes severity. Understanding this heterogeneity may inform prevention strategies to prevent dementia for all racial and ethnic groups.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S22)
Proportion of Dementia Cases in the Oldest‐old Attributable to 8 Neuropathological Changes: The 90+ Study
Background: People aged 90 and older have the highest rates of dementia. At advanced ages, dementia is due to a variety of diseases but the relative contribution of each is unknown. We estimated the proportion of dementia cases attributable to 8 different neuropathological indices in a cohort of individuals aged 90 and older.Methods: Participants (n = 425) are from The 90+ Autopsy Study, a community‐based longitudinal study of aging and cognition. Most participants (62.1%) were initially part of the Leisure World Cohort Study and the remaining were non‐cohort community volunteers (37.9%). The 8 neuropathologic features examined were Alzheimer’s disease neuropathologic change (ADNC), limbic predominant age‐related tdp‐43 encephalopathy (LATE‐NC), hippocampal sclerosis (HS), Lewy body disease (LBD), microvascular lesions (MVL), cerebral amyloid angiopathy (CAA), atherosclerosis, and arteriolosclerosis. We examined the association of the 8 neuropathologic features with all‐cause dementia using multivariable logistic regression adjusting for age, gender education, and cohort affiliation. We then estimated the proportion of dementia cases that could be attributed to each neuropathologic change.Results: Participants were on average 97.6 years at time of death, most were women (68%), and about half (43%) had dementia at time of death (Table 1). ADNC, LBD, LATE‐NC, arteriolosclerosis and atherosclerosis were significantly associated with dementia, whereas HS, MVLs, and CAA trended toward a significant association with dementia (Table 2). For the individual neuropathologic features, ADNC (26%) and arteriolosclerosis (24%) had the highest and similar attributable fraction of dementia cases, followed by LATE‐NC (17%) and CAA (10%) (Figure). When combinations of neuropathologic features were considered, vascular pathologic changes had the highest attributable fraction of dementia cases (38%), non‐AD changes (LBD, LATE‐NC, HS) had an attributable fraction of 28%, and LATE‐NC and HS combined had an attributable fraction of 20% (Figure). Overall, 78% of dementia cases could be attributed to these 8 neuropathologic features.Conclusions: Vascular pathologic changes, as a group, account for the largest fraction of dementia cases in this oldest‐old cohort. Furthermore, when considered together, non‐AD neuropathologic changes are as important contributors to dementia as ADNC. Therefore, interventions targeting a variety of diseases will be needed to significantly reduce the burden of dementia in the oldest‐old.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S22)
Open AccessProportion of Dementia Cases in the Oldest‐old Attributable to 8 Neuropathological Changes: The 90+ Study
Background: People aged 90 and older have the highest rates of dementia. At advanced ages, dementia is due to a variety of diseases but the relative contribution of each is unknown. We estimated the proportion of dementia cases attributable to 8 different neuropathological indices in a cohort of individuals aged 90 and older.Methods: Participants (n = 425) are from The 90+ Autopsy Study, a community‐based longitudinal study of aging and cognition. Most participants (62.1%) were initially part of the Leisure World Cohort Study and the remaining were non‐cohort community volunteers (37.9%). The 8 neuropathologic features examined were Alzheimer’s disease neuropathologic change (ADNC), limbic predominant age‐related tdp‐43 encephalopathy (LATE‐NC), hippocampal sclerosis (HS), Lewy body disease (LBD), microvascular lesions (MVL), cerebral amyloid angiopathy (CAA), atherosclerosis, and arteriolosclerosis. We examined the association of the 8 neuropathologic features with all‐cause dementia using multivariable logistic regression adjusting for age, gender education, and cohort affiliation. We then estimated the proportion of dementia cases that could be attributed to each neuropathologic change.Results: Participants were on average 97.6 years at time of death, most were women (68%), and about half (43%) had dementia at time of death (Table 1). ADNC, LBD, LATE‐NC, arteriolosclerosis and atherosclerosis were significantly associated with dementia, whereas HS, MVLs, and CAA trended toward a significant association with dementia (Table 2). For the individual neuropathologic features, ADNC (26%) and arteriolosclerosis (24%) had the highest and similar attributable fraction of dementia cases, followed by LATE‐NC (17%) and CAA (10%) (Figure). When combinations of neuropathologic features were considered, vascular pathologic changes had the highest attributable fraction of dementia cases (38%), non‐AD changes (LBD, LATE‐NC, HS) had an attributable fraction of 28%, and LATE‐NC and HS combined had an attributable fraction of 20% (Figure). Overall, 78% of dementia cases could be attributed to these 8 neuropathologic features.Conclusions: Vascular pathologic changes, as a group, account for the largest fraction of dementia cases in this oldest‐old cohort. Furthermore, when considered together, non‐AD neuropathologic changes are as important contributors to dementia as ADNC. Therefore, interventions targeting a variety of diseases will be needed to significantly reduce the burden of dementia in the oldest‐old.
- 23 January 2023
- Published by Wiley in Statistics in Medicine
- Vol. 42 (5) , 730
Corrigendum to: Fusion designs and estimators for treatment effects
- 23 January 2023
- Published by Wiley in Statistics in Medicine
- Vol. 42 (5) , 730
Corrigendum to: Fusion designs and estimators for treatment effects
- Open Access
- 8 August 2022
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 191 (11) , 1975-1980
Estimating Vaccine Effectiveness by Linking Population-Based Health Registries: Some Sources of Bias
The COVID-19 pandemic has underscored the importance of observational studies of real-world vaccine effectiveness to help answer urgent public health questions. One approach to rapidly answering questions about real-world vaccine effectiveness relies on linking data from a population-based registry of vaccinations with a population-based registry of health outcomes. Here we consider some potential sources of bias in linked registry studies including: incomplete reporting to the registries; errors in linking individuals between registries; and errors in the assumed population size of the catchment area of the registries. We show that the direction of the bias resulting from one source of error by itself is predictable. However, if multiple sources of error are present, the direction of the bias can be either upward or downward. The biases can be so strong as to make harmful vaccines appear effective. We provide explicit formulas to quantify and adjust for multiple biases in estimates of vaccine effectiveness which could be used in sensitivity analyses. While this work was motivated by COVID-19 vaccine questions, the results are generally applicable to studies that link population-based exposure registries with population-based case registries to estimate relative risks of exposures.
- 8 August 2022
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 191 (11) , 1975-1980
Open AccessEstimating Vaccine Effectiveness by Linking Population-Based Health Registries: Some Sources of Bias
The COVID-19 pandemic has underscored the importance of observational studies of real-world vaccine effectiveness to help answer urgent public health questions. One approach to rapidly answering questions about real-world vaccine effectiveness relies on linking data from a population-based registry of vaccinations with a population-based registry of health outcomes. Here we consider some potential sources of bias in linked registry studies including: incomplete reporting to the registries; errors in linking individuals between registries; and errors in the assumed population size of the catchment area of the registries. We show that the direction of the bias resulting from one source of error by itself is predictable. However, if multiple sources of error are present, the direction of the bias can be either upward or downward. The biases can be so strong as to make harmful vaccines appear effective. We provide explicit formulas to quantify and adjust for multiple biases in estimates of vaccine effectiveness which could be used in sensitivity analyses. While this work was motivated by COVID-19 vaccine questions, the results are generally applicable to studies that link population-based exposure registries with population-based case registries to estimate relative risks of exposures.
- Open Access
National Population-Level Disparities in COVID-19 Mortality Across the Intersection of Race/Ethnicity and Sex in the United States
Males and certain racial/ethnic minority groups have borne a disproportionate burden of COVID-19 mortality in the United States, and substantial scientific research has sought to quantify and characterize population-level disparities in COVID-19 mortality outcomes by sex and across categories of race/ethnicity. However, there has not yet been a national population-level study to quantify disparities in COVID-19 mortality outcomes across the intersection of these demographic dimensions. Here, we analyze a publicly available dataset from the National Center for Health Statistics comprising COVID-19 death counts stratified by race/ethnicity, sex, and age for the year 2020, calculating mortality rates for each race/ethnicity-sex-age stratum and age-adjusted mortality rates for each race/ethnicity-sex stratum, quantifying disparities in terms of mortality rate ratios and rate differences. Our results reveal persistently higher COVID-19 age-adjusted mortality rates for males compared to females within every racial/ethnic group, with notable variation in the magnitudes of the sex disparity by race/ethnicity. However, non-Hispanic Black, Hispanic, and non-Hispanic American Indian or Alaska Native females have higher age-adjusted mortality rates than non-Hispanic White and non-Hispanic Asian/Pacific Islander males. Moreover, persistent racial/ethnic disparities are observed among both males and females, with higher COVID-19 age-adjusted mortality rates observed for non-Hispanic Blacks, Hispanics, and non-Hispanic American Indian or Alaska Natives relative to non-Hispanic Whites.
Open AccessNational Population-Level Disparities in COVID-19 Mortality Across the Intersection of Race/Ethnicity and Sex in the United States
Males and certain racial/ethnic minority groups have borne a disproportionate burden of COVID-19 mortality in the United States, and substantial scientific research has sought to quantify and characterize population-level disparities in COVID-19 mortality outcomes by sex and across categories of race/ethnicity. However, there has not yet been a national population-level study to quantify disparities in COVID-19 mortality outcomes across the intersection of these demographic dimensions. Here, we analyze a publicly available dataset from the National Center for Health Statistics comprising COVID-19 death counts stratified by race/ethnicity, sex, and age for the year 2020, calculating mortality rates for each race/ethnicity-sex-age stratum and age-adjusted mortality rates for each race/ethnicity-sex stratum, quantifying disparities in terms of mortality rate ratios and rate differences. Our results reveal persistently higher COVID-19 age-adjusted mortality rates for males compared to females within every racial/ethnic group, with notable variation in the magnitudes of the sex disparity by race/ethnicity. However, non-Hispanic Black, Hispanic, and non-Hispanic American Indian or Alaska Native females have higher age-adjusted mortality rates than non-Hispanic White and non-Hispanic Asian/Pacific Islander males. Moreover, persistent racial/ethnic disparities are observed among both males and females, with higher COVID-19 age-adjusted mortality rates observed for non-Hispanic Blacks, Hispanics, and non-Hispanic American Indian or Alaska Natives relative to non-Hispanic Whites.
- Open Access
- 12 August 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (16) , 7403
Male-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis
Males are at higher risk relative to females of severe outcomes following COVID-19 infection. Focusing on COVID-19-attributable mortality in the United States (U.S.), we quantified and contrasted years of potential life lost (YPLL) attributable to COVID-19 by sex based on data from the U.S. National Center for Health Statistics as of 31 March 2021, specifically by contrasting male and female percentages of total YPLL with their respective percent population shares and calculating age-adjusted male-to-female YPLL rate ratios, both nationally and for each of the 50 states and the District of Columbia. Using YPLL before age 75 to anchor comparisons between males and females and a novel Monte Carlo simulation procedure to perform estimation and uncertainty quantification, our results reveal a near-universal pattern across states of higher COVID-19-attributable YPLL among males compared to females. Furthermore, the disproportionately high COVID-19 mortality burden among males is generally more pronounced when measuring mortality burden in terms of YPLL compared to death counts, reflecting dual phenomena of males dying from COVID-19 at higher rates and at systematically younger ages relative to females. The U.S. COVID-19 epidemic also offers lessons underscoring the importance of cultivating a public health environment that recognizes sex-specific needs as well as different patterns in risk factors, health behaviors, and responses to interventions between men and women. Public health strategies incorporating focused efforts to increase COVID-19 vaccinations among men are particularly urged.
- 12 August 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (16) , 7403
Open AccessMale-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis
Males are at higher risk relative to females of severe outcomes following COVID-19 infection. Focusing on COVID-19-attributable mortality in the United States (U.S.), we quantified and contrasted years of potential life lost (YPLL) attributable to COVID-19 by sex based on data from the U.S. National Center for Health Statistics as of 31 March 2021, specifically by contrasting male and female percentages of total YPLL with their respective percent population shares and calculating age-adjusted male-to-female YPLL rate ratios, both nationally and for each of the 50 states and the District of Columbia. Using YPLL before age 75 to anchor comparisons between males and females and a novel Monte Carlo simulation procedure to perform estimation and uncertainty quantification, our results reveal a near-universal pattern across states of higher COVID-19-attributable YPLL among males compared to females. Furthermore, the disproportionately high COVID-19 mortality burden among males is generally more pronounced when measuring mortality burden in terms of YPLL compared to death counts, reflecting dual phenomena of males dying from COVID-19 at higher rates and at systematically younger ages relative to females. The U.S. COVID-19 epidemic also offers lessons underscoring the importance of cultivating a public health environment that recognizes sex-specific needs as well as different patterns in risk factors, health behaviors, and responses to interventions between men and women. Public health strategies incorporating focused efforts to increase COVID-19 vaccinations among men are particularly urged.
- Open Access
- 8 May 2021
- Published by Wiley in Statistics in Medicine
- Vol. 40 (11) , 2521-2523
Commentary on the role of statisticians in pandemics
- 8 May 2021
- Published by Wiley in Statistics in Medicine
- Vol. 40 (11) , 2521-2523
Open AccessCommentary on the role of statisticians in pandemics
- Open Access
Male-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis
Males are at higher risk relative to females of severe outcomes following COVID-19 infection. Focusing on COVID-19-attributable mortality in the United States (U.S.), we quantify and contrast years of potential life lost (YPLL) attributable to COVID-19 by sex based on data from the U.S. National Center for Health Statistics as of 31 March 2021, specifically by contrasting male and female percentages of total YPLL with their respective percent population shares and calculating age-adjusted male-to-female YPLL rate ratios both nationally and for each of the 50 states and the District of Columbia. Using YPLL before age 75 to anchor comparisons between males and females and a novel Monte Carlo simulation procedure to perform estimation and uncertainty quantification, our results reveal a near-universal pattern across states of higher COVID-19-attributable YPLL among males compared to females. Furthermore, the disproportionately high COVID-19 mortality burden among males is generally more pronounced when measuring mortality in terms of YPLL compared to age-irrespective death counts, reflecting dual phenomena of males dying from COVID-19 at higher rates and at systematically younger ages relative to females. The U.S. COVID-19 epidemic also offers lessons underscoring the importance of a public health environment that recognizes sex-specific needs as well as different patterns in risk factors, health behaviors, and responses to interventions between men and women. Public health strategies incorporating focused efforts to increase COVID-19 vaccinations among men are particularly urged.
Open AccessMale-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis
Males are at higher risk relative to females of severe outcomes following COVID-19 infection. Focusing on COVID-19-attributable mortality in the United States (U.S.), we quantify and contrast years of potential life lost (YPLL) attributable to COVID-19 by sex based on data from the U.S. National Center for Health Statistics as of 31 March 2021, specifically by contrasting male and female percentages of total YPLL with their respective percent population shares and calculating age-adjusted male-to-female YPLL rate ratios both nationally and for each of the 50 states and the District of Columbia. Using YPLL before age 75 to anchor comparisons between males and females and a novel Monte Carlo simulation procedure to perform estimation and uncertainty quantification, our results reveal a near-universal pattern across states of higher COVID-19-attributable YPLL among males compared to females. Furthermore, the disproportionately high COVID-19 mortality burden among males is generally more pronounced when measuring mortality in terms of YPLL compared to age-irrespective death counts, reflecting dual phenomena of males dying from COVID-19 at higher rates and at systematically younger ages relative to females. The U.S. COVID-19 epidemic also offers lessons underscoring the importance of a public health environment that recognizes sex-specific needs as well as different patterns in risk factors, health behaviors, and responses to interventions between men and women. Public health strategies incorporating focused efforts to increase COVID-19 vaccinations among men are particularly urged.